Precision medicine and radiogenomics in breast cancer: new approaches toward diagnosis and treatment

K Pinker, J Chin, AN Melsaether, EA Morris, L Moy - Radiology, 2018 - pubs.rsna.org
Precision medicine is medicine optimized to the genotypic and phenotypic characteristics of
an individual and, when present, his or her disease. It has a host of targets, including genes …

Quantification of tumor heterogeneity: from data acquisition to metric generation

A Kashyap, MA Rapsomaniki, V Barros… - Trends in …, 2022 - cell.com
Tumors are unique and complex ecosystems, in which heterogeneous cell subpopulations
with variable molecular profiles, aggressiveness, and proliferation potential coexist and …

Background, current role, and potential applications of radiogenomics

K Pinker, F Shitano, E Sala, RK Do… - Journal of Magnetic …, 2018 - Wiley Online Library
With the genomic revolution in the early 1990s, medical research has been driven to study
the basis of human disease on a genomic level and to devise precise cancer therapies …

Role of texture analysis in breast MRI as a cancer biomarker: A review

RD Chitalia, D Kontos - Journal of Magnetic Resonance …, 2019 - Wiley Online Library
Breast cancer is a known heterogeneous disease. Current clinically utilized histopathologic
biomarkers may undersample tumor heterogeneity, resulting in higher rates of misdiagnosis …

Imaging phenotypes of breast cancer heterogeneity in preoperative breast dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) scans predict 10-year …

RD Chitalia, J Rowland, ES McDonald… - Clinical Cancer …, 2020 - AACR
Purpose: Identifying imaging phenotypes and understanding their relationship with
prognostic markers and patient outcomes can allow for a noninvasive assessment of cancer …

[HTML][HTML] Breast cancer classification through multivariate radiomic time series analysis in DCE-MRI sequences

F Prinzi, A Orlando, S Gaglio, S Vitabile - Expert Systems with Applications, 2024 - Elsevier
Breast cancer is the most prevalent disease that poses a significant threat to women's
health. Despite the Dynamic Contrast-Enhanced MRI (DCE-MRI) has been widely used for …

DCE‐MRI texture analysis with tumor subregion partitioning for predicting Ki‐67 status of estrogen receptor‐positive breast cancers

M Fan, H Cheng, P Zhang, X Gao… - Journal of Magnetic …, 2018 - Wiley Online Library
Background Breast tumor heterogeneity is related to risk factors that lead to worse
prognosis, yet such heterogeneity has not been well studied. Purpose To predict the Ki‐67 …

Precision diagnostics based on machine learning-derived imaging signatures

C Davatzikos, A Sotiras, Y Fan, M Habes, G Erus… - Magnetic resonance …, 2019 - Elsevier
The complexity of modern multi-parametric MRI has increasingly challenged conventional
interpretations of such images. Machine learning has emerged as a powerful approach to …

Pharmacokinetic tumor heterogeneity as a prognostic biomarker for classifying breast cancer recurrence risk

M Mahrooghy, AB Ashraf, D Daye… - IEEE Transactions …, 2015 - ieeexplore.ieee.org
Goal: Heterogeneity in cancer can affect response to therapy and patient prognosis.
Histologic measures have classically been used to measure heterogeneity, although a …

Heterogeneity in intratumoral regions with rapid gadolinium washout correlates with estrogen receptor status and nodal metastasis

B Chaudhury, M Zhou, DB Goldgof… - Journal of Magnetic …, 2015 - Wiley Online Library
Purpose To evaluate heterogeneity within tumor subregions or “habitats” via textural kinetic
analysis on breast dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) for …